Results 101 to 110 of about 6,305 (206)

Immunoconjugates in cervical cancer: a bibliometric and thematic mapping analysis of global research trends, 2015-2024. [PDF]

Front Oncol
Wang X, Xiong D, Cui S, Duan B, Ding G, Huang Y, Wang Q.   +6 more
europepmc   +1 more source

Immunomagnetic Sample Preparation Targeting Host- and Viral-Derived Antigens for HIV-1 Isolation from Limited Plasma Volumes. [PDF]

Anal Chem
Gulati GK, Panpradist N, Lutz BR, Lai JJ.   +3 more
europepmc   +1 more source

Theranostic vNAR-Based Immunoconjugates Achieve Selective Intracellular Cisplatin Delivery in Embedded 3D HER2-Positive Breast Cancer In Vitro Model. [PDF]

Pharmaceuticals (Basel)
Alfonseca-Ladrón de Guevara AC, Manzanares-Guzmán A, Badillo-Mata JA, Burciaga-Flores M, Lugo-Fabres PH, Camacho-Villegas TA.   +5 more
europepmc   +1 more source

Selective Chemistry Enables Simultaneous ImmunoPET and Radioimmunotherapy with a Dual-Labeled Probe. [PDF]

JACS Au
Kao WM, Grimaldi C, Samuels ZV, Dehlavi G, Strugala E, Cornejo M, Sebastiano J, Carter LM, Zeglis BM.   +8 more
europepmc   +1 more source

Comparative In Vitro Evaluation of Anti-HIV Immunotoxin, Antibody-Drug Conjugate, and Radioimmunoconjugate Targeted by the Same Antibody. [PDF]

Antibodies (Basel)
Kuhlmann AS, Peters T, Hamlin DK, Li Y, Wang X, Stackhouse M, Cole FM, Martinez-Reyes J, Sandmaier BM, Kiem HP, Wilbur DS, Harrington RD, Pincus SH.   +12 more
europepmc   +1 more source

Development of Optimized Exatecan-Based Immunoconjugates with Potent Antitumor Efficacy in HER2-Positive Breast Cancer. [PDF]

J Med Chem
Auvert E, Douez E, Jolivet L, Witkowski T, Jallas AC, Boursin F, Molnar I, Colas C, Wittmann SV, Auriol M, Chezal JM, Aubrey N, Allard-Vannier E, Maisonial-Besset A, Joubert N, Denevault-Sabourin C.   +15 more
europepmc   +1 more source

LINGO1-targeted antibody-drug conjugates improve efficacy and tolerability of antineoplastic therapies in Ewing sarcoma models. [PDF]

J Clin Invest
Zhu Z, Liu Y, Deng Y, Li Z, Baldwin AS, Liu P.   +5 more
europepmc   +1 more source

Preclinical characterization of 3p-C-DEPA_-NCS and 3p-C-DEPA_-TFP-PEG₄ as potential Actinium-225 bifunctional chelators using DOTA_-NCS and macropa_-NCS as benchmarks. [PDF]

EJNMMI Radiopharm Chem
Pougoue Ketchemen J, Ahenkorah S, Nwangele E, Malaza SSP, Ooms M, Cardinaels T, Leekens S, Cleeren F, Fonge H.   +8 more
europepmc   +1 more source

The Next Wave of Immunotherapy: A Critical Review of Nanotechnology Strategies for Immune Checkpoint Blockade. [PDF]

Pharmaceutics
Almuqbil RM.
europepmc   +1 more source

Harnessing Fc-Directed Bioconjugation for the Synthesis of Site-Specifically Modified Radioimmunoconjugates. [PDF]

Bioconjug Chem
Grimaldi C, Sebastiano J, Kao WM, Strugala E, McGlone SA, Watanabe T, Aoki T, Fujii T, Zeglis BM.   +8 more
europepmc   +1 more source